Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT07266402

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Led by Celldex Therapeutics · Updated on 2026-05-08

240

Participants Needed

72

Research Sites

141 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or symptomatic dermographism who remain symptomatic despite the use of H1-antihistamines.

CONDITIONS

Official Title

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Males and females 18 years of age or older
  • Diagnosis of cold induced urticaria or symptomatic dermographism for at least 3 months
  • Presence of hives for at least 6 weeks despite using H1-antihistamines
  • Stable regimen of second generation non-sedating H1-antihistamines for at least 4 weeks before treatment
  • For cold induced urticaria, Critical Threshold Temperature between 15 6C and less than 37 6C and itch score of 5 or more after provocation test
  • For symptomatic dermographism, Critical Friction Threshold of 3 or more and itch score of 5 or more after provocation test
  • Positive ice-cube test with hives at provocation site during screening for cold induced urticaria
  • Normal blood counts and liver function tests
  • Both males and females of child-bearing potential must agree to use highly effective contraceptives during the study and for at least 150 days after treatment
  • Willing and able to complete a daily symptom electronic diary and comply with study visits
  • Participants with or without prior biologic experience are eligible
Not Eligible

You will not qualify if you...

  • Women who are pregnant or nursing
  • Clearly defined cause for chronic urticaria
  • Active, itchy skin condition in addition to cold induced urticaria or symptomatic dermographism
  • Medical conditions that increase risk or interfere with study procedures
  • Known HIV, hepatitis B, or hepatitis C infection
  • Vaccination with a live vaccine within 30 days prior to screening or during the study
  • History of anaphylaxis unless due to cold exposure over a large part of the body
  • Prior treatment with barzolvolimab

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 72 locations

1

Cahaba Dermatology & Skin Health Center, LLC

Birmingham, Alabama, United States, 35244

Actively Recruiting

2

One of a Kind Clinical Research Center, LLC

Scottsdale, Arizona, United States, 85258

Actively Recruiting

3

Kern Research, Inc.

Bakersfield, California, United States, 93301

Actively Recruiting

4

One of a Kind Clinical Research Center

Napa, California, United States, 94558

Actively Recruiting

5

Allergy & Asthma Consultants

Redwood City, California, United States, 94063

Actively Recruiting

6

Amicis Research Center

Sherman Oaks, California, United States, 91403

Actively Recruiting

7

FOMAT - Allergy, Asthma & Immunology Medical Group

Ventura, California, United States, 93003

Actively Recruiting

8

Direct Helpers Research Center

Hialeah, Florida, United States, 33012

Actively Recruiting

9

Well Pharma Medical Research, Corp.

Miami, Florida, United States, 33143

Actively Recruiting

10

Deluxe Health Center, LLC

Miami Lakes, Florida, United States, 33014

Actively Recruiting

11

GCP, Global Clinical Professionals

St. Petersburg, Florida, United States, 33705

Actively Recruiting

12

Advanced Clinical Research Institute

Tampa, Florida, United States, 33607

Actively Recruiting

13

Centricity Research Columbus Dermatology

Columbus, Georgia, United States, 31904

Actively Recruiting

14

Treasure Valley Medical Research

Boise, Idaho, United States, 83706

Actively Recruiting

15

Endeavor Health Clinical Trials Center

Skokie, Illinois, United States, 60077

Actively Recruiting

16

Equity Medical, LLC

Bowling Green, Kentucky, United States, 42104

Actively Recruiting

17

Advanced ENT and Allergy, PLLC

Louisville, Kentucky, United States, 40207

Actively Recruiting

18

Johns Hopkins University

Baltimore, Maryland, United States, 21224

Actively Recruiting

19

Revival Research Institute, LLC

Troy, Michigan, United States, 48084

Actively Recruiting

20

Equity Medical, LLC

New York, New York, United States, 10023

Actively Recruiting

21

Markowitz Medical PLLC dba OptiSkin Medical

New York, New York, United States, 10128

Actively Recruiting

22

University of Cincinnati

Cincinnati, Ohio, United States, 45267

Not Yet Recruiting

23

Allergy, Asthma & Clinical Research Center

Oklahoma City, Oklahoma, United States, 73120

Actively Recruiting

24

Advanced Dermatology and Cosmetic Surgery - Spartanburg

Spartanburg, South Carolina, United States, 29307

Actively Recruiting

25

RFSA Dermatology

San Antonio, Texas, United States, 78212

Actively Recruiting

26

Allergy Associates of Utah

Sandy City, Utah, United States, 84093

Actively Recruiting

27

Universitätsklinikum Augsburg - III. Med. Klinik

Augsburg, Germany

Not Yet Recruiting

28

Institut für Allergieforschung (IFA) Charité - Universitätsmedizin Berlin

Berlin, Germany

Not Yet Recruiting

29

Elbekliniken Buxtehude

Buxtehude, Germany

Actively Recruiting

30

Rosenpark Research

Darmstadt, Germany

Actively Recruiting

31

University Hospital Dresden

Dresden, Germany

Not Yet Recruiting

32

University Hospital Düsseldorf

Düsseldorf, Germany

Not Yet Recruiting

33

Universitatsklinkum Erlangen-Ulmenweg 18

Erlangen, Germany

Not Yet Recruiting

34

Universitätsklinikum Göttingen

Göttingen, Germany

Not Yet Recruiting

35

Universitätsklinikum Heidelberg

Heidelberg, Germany

Not Yet Recruiting

36

MVZ DermaKiel GmbH

Kiel, Germany

Not Yet Recruiting

37

Universitätsklinikum Schleswig-Holstein - Campus Lübeck

Lübeck, Germany

Actively Recruiting

38

LMU Klinikum der Universität

München, Germany

Not Yet Recruiting

39

Universitätsklinikum Münster, Klinik u. Poliklinik f. Dermatologie

Münster, Germany

Actively Recruiting

40

Universitäts-Hautklinik Tübingen

Tübingen, Germany

Actively Recruiting

41

CD8 Klinika

Kaunas, Lithuania

Actively Recruiting

42

UAB Ausros Medicinos Centras

Kaunas, Lithuania

Actively Recruiting

43

Republic Klaipeda Hospital

Klaipėda, Lithuania

Not Yet Recruiting

44

Santaros KTC (klinikiniu tyrimu centras)

Vilnius, Lithuania

Actively Recruiting

45

UAB Alerginių susirgimų diagnostikos ir gydymo centras

Vilnius, Lithuania

Actively Recruiting

46

Centrum Medyczne ALL-MED Badania Kliniczne

Krakow, Poland

Not Yet Recruiting

47

Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o.

Krakow, Poland

Actively Recruiting

48

"Oddzial Kliniczny Chorob Wewnetrznych, Astmy i Alergii z Odcinkiem dla Dzieci, Uniwersytecki Szpital Kliniczny nr 1 w Lodzi"

Lodz, Poland

Not Yet Recruiting

49

Santa Familia PTG Lodz

Lodz, Poland

Actively Recruiting

50

Luxderm Specjalistyczny Gabinet Dermatologiczny Prof. dr hab. N. med. Dorota Krasowska

Lublin, Poland

Not Yet Recruiting

51

Uniwersytecki Szpital Kliniczny w Opolu

Opole, Poland

Not Yet Recruiting

52

Medicome Sp. z o.o.

Oświęcim, Poland

Actively Recruiting

53

EMC Instytut Medyczny S.A.PL CERTUS Szpital i Ambulatorium

Poznan, Poland

Not Yet Recruiting

54

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie

Rzeszów, Poland

Not Yet Recruiting

55

Alergo-med Ośrodek Badań Klinicznych Spólka z ograniczoną odpowiedzialnością

Tarnów, Poland

Not Yet Recruiting

56

MICS Centrum Medyczne Toruń

Torun, Poland

Not Yet Recruiting

57

Klinika Ambroziak Dermatologia

Warsaw, Poland

Actively Recruiting

58

Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Sp. Partnerska

Wroclaw, Poland

Actively Recruiting

59

Worthwhile Clinical Trials

Benoni, South Africa

Not Yet Recruiting

60

Allergy and Immunology Unit, University of Cape Town Lung Institute (UCTLI)

Cape Town, South Africa

Actively Recruiting

61

Dr. PJ Sebastian

Durban, South Africa

Actively Recruiting

62

Infinity Dermatology Inc

Durban, South Africa

Actively Recruiting

63

Synapta Clinical Research Centre

Durban, South Africa

Actively Recruiting

64

Newtown Clinical Research Centre

Johannesburg, South Africa

Actively Recruiting

65

Sandton Medical Research Centre

Johannesburg, South Africa

Actively Recruiting

66

Global Clinical Trials (Pty) Ltd

Pretoria, South Africa

Actively Recruiting

67

Allergy and Asthma Centre

Westville, South Africa

Actively Recruiting

68

Hospital del Mar

Barcelona, Spain

Actively Recruiting

69

Clinica Universidad Navarra - Pamplona

Pamplona, Spain

Actively Recruiting

70

Addenbrooke's Hospital

Cambridge, United Kingdom

Not Yet Recruiting

71

Queen Elizabeth University Hospital

Glasgow, United Kingdom

Not Yet Recruiting

72

Salford Care Organisation NCA NHS Trust

Manchester, United Kingdom

Not Yet Recruiting

Loading map...

Research Team

C

Celldex Therapeutics

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD) | DecenTrialz